214 related articles for article (PubMed ID: 9119983)
1. Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-alpha inhibitor.
Clements JM; Cossins JA; Wells GM; Corkill DJ; Helfrich K; Wood LM; Pigott R; Stabler G; Ward GA; Gearing AJ; Miller KM
J Neuroimmunol; 1997 Apr; 74(1-2):85-94. PubMed ID: 9119983
[TBL] [Abstract][Full Text] [Related]
2. A combined inhibitor of matrix metalloproteinase activity and tumour necrosis factor-alpha processing attenuates experimental autoimmune neuritis.
Redford EJ; Smith KJ; Gregson NA; Davies M; Hughes P; Gearing AJ; Miller K; Hughes RA
Brain; 1997 Oct; 120 ( Pt 10)():1895-905. PubMed ID: 9365379
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis.
Kieseier BC; Kiefer R; Clements JM; Miller K; Wells GM; Schweitzer T; Gearing AJ; Hartung HP
Brain; 1998 Jan; 121 ( Pt 1)():159-66. PubMed ID: 9549496
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase expression during experimental autoimmune neuritis.
Hughes PM; Wells GM; Clements JM; Gearing AJ; Redford EJ; Davies M; Smith KJ; Hughes RA; Brown MC; Miller KM
Brain; 1998 Mar; 121 ( Pt 3)():481-94. PubMed ID: 9549524
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of matrix metalloproteinases and tumour necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis.
Leib SL; Clements JM; Lindberg RL; Heimgartner C; Loeffler JM; Pfister LA; Täuber MG; Leppert D
Brain; 2001 Sep; 124(Pt 9):1734-42. PubMed ID: 11522576
[TBL] [Abstract][Full Text] [Related]
6. Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors.
Liedtke W; Cannella B; Mazzaccaro RJ; Clements JM; Miller KM; Wucherpfennig KW; Gearing AJ; Raine CS
Ann Neurol; 1998 Jul; 44(1):35-46. PubMed ID: 9667591
[TBL] [Abstract][Full Text] [Related]
7. Anti-arthritic activity of hydroxamic acid-based pseudopeptide inhibitors of matrix metalloproteinases and TNF alpha processing.
DiMartino M; Wolff C; High W; Stroup G; Hoffman S; Laydon J; Lee JC; Bertolini D; Galloway WA; Crimmin MJ; Davis M; Davies S
Inflamm Res; 1997 Jun; 46(6):211-5. PubMed ID: 9243304
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain.
Rosenberg GA; Estrada EY; Dencoff JE
Stroke; 1998 Oct; 29(10):2189-95. PubMed ID: 9756602
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states.
Pagenstecher A; Stalder AK; Kincaid CL; Shapiro SD; Campbell IL
Am J Pathol; 1998 Mar; 152(3):729-41. PubMed ID: 9502415
[TBL] [Abstract][Full Text] [Related]
10. Coordinated induction of extracellular proteolysis systems during experimental autoimmune encephalomyelitis in mice.
Teesalu T; Hinkkanen AE; Vaheri A
Am J Pathol; 2001 Dec; 159(6):2227-37. PubMed ID: 11733372
[TBL] [Abstract][Full Text] [Related]
11. Increased matrix metalloproteinases in the aqueous humor of patients and experimental animals with uveitis.
Di Girolamo N; Verma MJ; McCluskey PJ; Lloyd A; Wakefield D
Curr Eye Res; 1996 Oct; 15(10):1060-8. PubMed ID: 8921246
[TBL] [Abstract][Full Text] [Related]
12. Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790.
Hewson AK; Smith T; Leonard JP; Cuzner ML
Inflamm Res; 1995 Aug; 44(8):345-9. PubMed ID: 8581522
[TBL] [Abstract][Full Text] [Related]
13. Delayed-type hypersensitivity lesions in the central nervous system are prevented by inhibitors of matrix metalloproteinases.
Matyszak MK; Perry VH
J Neuroimmunol; 1996 Sep; 69(1-2):141-9. PubMed ID: 8823386
[TBL] [Abstract][Full Text] [Related]
14. The matrix metalloproteinase inhibitor BB-1101 prevents experimental autoimmune uveoretinitis (EAU).
Wallace GR; Whiston RA; Stanford MR; Wells GM; Gearing AJ; Clements JM
Clin Exp Immunol; 1999 Dec; 118(3):364-70. PubMed ID: 10594553
[TBL] [Abstract][Full Text] [Related]
15. Minocycline suppresses experimental autoimmune encephalomyelitis by increasing tissue inhibitors of metalloproteinases.
Niimi N; Kohyama K; Matsumoto Y
Neuropathology; 2013 Dec; 33(6):612-20. PubMed ID: 23581743
[TBL] [Abstract][Full Text] [Related]
16. Effect of a matrix metalloproteinase inhibitor (BB-1101) on nerve regeneration.
Demestre M; Gregson NA; Smith KJ; Miller KM; Gearing AJ; Hughes RA
Ann N Y Acad Sci; 1999 Jun; 878():658-61. PubMed ID: 10415800
[No Abstract] [Full Text] [Related]
17. Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the Guillain-Barré syndrome.
Kieseier BC; Clements JM; Pischel HB; Wells GM; Miller K; Gearing AJ; Hartung HP
Ann Neurol; 1998 Apr; 43(4):427-34. PubMed ID: 9546322
[TBL] [Abstract][Full Text] [Related]
18. The interrelationship of alpha4 integrin and matrix metalloproteinase-2 in the pathogenesis of experimental autoimmune encephalomyelitis.
Graesser D; Mahooti S; Haas T; Davis S; Clark RB; Madri JA
Lab Invest; 1998 Nov; 78(11):1445-58. PubMed ID: 9840619
[TBL] [Abstract][Full Text] [Related]
19. Cytokine-mediated modulation of MMPs and TIMPs in multipotential neural precursor cells.
Ben-Hur T; Ben-Yosef Y; Mizrachi-Kol R; Ben-Menachem O; Miller A
J Neuroimmunol; 2006 Jun; 175(1-2):12-8. PubMed ID: 16580738
[TBL] [Abstract][Full Text] [Related]
20. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
Feng M; Shu Y; Yang Y; Zheng X; Li R; Wang Y; Dai Y; Qiu W; Lu Z; Hu X
Neurochem Int; 2014 Jan; 64():64-72. PubMed ID: 24274996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
